Page 11 - மருத்துவ ஆய்வகம் முன்னேற்றம் திருத்தங்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

MedMira Closes New Equity Investment for Future Growth

Article content HALIFAX, Nova Scotia, July 14, 2021 (GLOBE NEWSWIRE) Today, MedMira Inc. (MedMira) (TSXV: MIR) has closed a CAD$ 0.5 million equity investment with a Canadian arm’s length investor. The investment is strictly aimed to increase the Company’s growing operational capacity and represents fully diluted less than 1% of the total shareholding. The transaction was approved by the TSX Venture Exchange. Under the terms of deal, the investor will acquire 2,711,496 equity units at $0.18444 per unit. Each equity unit consists of one common share and one common share purchase warrant and is subject to the four month hold period. Each full warrant entitles the investor to purchase one common share of MedMira at $0.18444 per share exercisable over six months.

United statesMarkus meileHermes chanUs congressMedmira incClinical laboratory improvement amendmentsEuropean unionRegulation services providerVenture exchangeNova scotiaRapid verticalஒன்றுபட்டது மாநிலங்களில்ஹெர்ம்ஸ் சான்எங்களுக்கு காங்கிரஸ்மருத்துவ ஆய்வகம் முன்னேற்றம் திருத்தங்கள்ஐரோப்பிய தொழிற்சங்கம்

New Brigham–Wyss Diagnostic Accelerator could enable fast creation of diagnostic technologies

New Brigham–Wyss Diagnostic Accelerator could enable fast creation of diagnostic technologies Today, the Wyss Institute for Biologically Inspired Engineering at Harvard University and Boston s Brigham and Women Hospital (Brigham) announce their newly founded Diagnostic Accelerator (Brigham-Wyss DxA). By combining the institutions broad clinical and multi-disciplinary bioengineering expertise, the Brigham-Wyss DxA will enable the fast creation of diagnostic technologies through deep collaborations in a process driven by previously unmet needs. The Brigham-Wyss DxA presents a new type of research collaboration with the potential to significantly compress the timeframe for introducing new diagnostic technologies specifically developed to solve high-value clinical problems. The collaborators plan to achieve this through a formal process by which unmet diagnostic challenges are identified by the Brigham clinical community, effectively matched with highly appropriate technologies crea

United statesDavid waltRushdy ahmadWyss dxa biomarkerPaul andersonBrigham wyss dxDonald ingberEmily hendersonInternational wyss institute symposiumBrigham clinical laboratory diagnostic acceleratorHoward hughes medical institute professorBrigham innovation officeQuanterix corpClinical laboratory improvement amendmentsWyss instituteIllumina inc

Harvard s Wyss Institute and Brigham and Women s Hospital

Harvard s Wyss Institute and Brigham and Women s Hospital
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

United statesDavid waltPaul andersonWyss dxInternational wyss institute symposiumHoward hughes medical institute professorBrigham innovation officeQuanterix corpWyss instituteClinical laboratory improvement amendmentsHarvard office of technology developmentIllumina incBiologically inspired engineeringHarvard universityWomen hospitalDiagnostic accelerator

Harvard s Wyss Institute and Brigham and Women s Hospital launch diagnostic accelerator

Harvard s Wyss Institute and Brigham and Women s Hospital launch diagnostic accelerator
eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.

Boston universityUnited statesUniversity of massachusetts medical schoolMassachusetts institute of technologyFaulkner hospitalDana farber cancer instituteTufts universitySpaulding rehabilitation hospitalDavid waltRushdy ahmadWyss dxa biomarkerPaul andersonBrigham wyss dxDonald ingberBenjamin boettnerBeth israel deaconess medical center

Ortho Clinical Diagnostics Quantitative COVID-19 IgG Antibody Test First to Receive FDA Emergency Use Authorization

Ortho Clinical Diagnostics Quantitative COVID-19 IgG Antibody Test First to Receive FDA Emergency Use Authorization
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Ivan salgoClinical laboratory improvement amendmentsInternational standardWorld health organizationDrug administrationTesting solutionsOrtho clinical diagnosticsEmergency use authorizationOrtho clinicalAntibody testsClinical diagnosticsBecause every testAccessed julyமருத்துவ ஆய்வகம் முன்னேற்றம் திருத்தங்கள்சர்வதேச தரநிலைஉலகம் ஆரோக்கியம் ஆர்கநைஸேஶந்